HOMEVULNERABILITIESCVE-2023-38958
MEDIUM

CVE-2023-38958

CWE-863Published: August 3, 2023· Updated: Jul 9, 2026

5.3
CVSS v3.1

Official Description

An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open the doors managed by the platform remotely via sending a crafted web request.

NVD Source

Technical Analysis

CVE-2023-38958 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityNone
IntegrityLow
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N

Affected Vendors & Products

zkteco1 product(s)
bioaccess ivs
Source: NVD CPE · 1 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (2)

Quick Facts

CVE IDCVE-2023-38958
CVSS Score5.3 / 10
SeverityMEDIUM
WeaknessCWE-863
CISA KEVNo
Affected1 vendor(s)
PublishedAug 3, 2023

Related CVEs (CWE-863)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2023-38958 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.